Clinical Trial: NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06402565) titled 'NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers' on April 23.

Brief Summary: The goal of this multi-center, randomized, placebo-controlled, evaluator-blinded study is to assess the safety and efficacy of NOX1416 in the treatment of chronic, non-healing, diabetic foot ulcers (DFUs). Subjects will be randomized to receive treatment with NOX1416 or placebo, as an adjunct to Standard of Care (SOC).

The primary objective of the study is to demonstrate the safety and tolerability of NOX1416 as adjunct to SOC. The secondary objective is to evaluate the clinical benefit of daily NOX1416, as an adjunct to standard of care SOC...